1Yildirim-Assaf S, Coumbos A, Hopfenmuller W, Foss HD, Stein H, Ktlhn W. The prognostic significance of determining DNA content in breast cancer by DNA image cytometry:The role of high grade aneuploidy in node negative breast cancer. J Clin Pathol, 2007 ,Jun ,60(6) :649-655.
2Chavez-Uribe E, Cameselle-Teijeiro J, Vinuela JE, Castro-Pineiro C, Gude F, Forteza J, Puente-Dominguez JL. Hypoploidy defines patients with poor prognosis in breast cancer. Oncol Rep,2007, May,17(5) :1109-1114.
3Sgambato A, Doki Y, Schieren I, et al. Effects of cyclin E overexpression on cell growth and response to transforming growth factor beta depend on cell context and p27Kip1 expression. Cell Growth Differ, 1997,8 ( 4 ) : 393 -405.
4Wang L, Shan ZM. Cyelin e expression and prognosis in breast cancer patients:a meta-analysis of published studies. Cancer Invest,2006,Oct,24(6) :581-587.
7Railo M, Lundin J, Haglund C,von Smitten K, Nordling S. Ki-67, p53,ER receptors, ploidy and S phase as long-term prognostic factors in T1 node-negative breast cancer. Tumour Biol,2007,28 ( 1 ) :45-51. Epub 2006 Dec 1.
8Carreno G, Del Casar JM, Corte MD, et al. Local recurrence after mastectomy for breast cancer: analysis of clinicopathological, biological and prognostic characteristics. Breast Cancer Res Treat, 2006, Jul, 19.
7[1]Gori S,Mosconi AM,Basurtol C,et al.Weekly paclitaxel in metastatic breast cancer patients:a phase Ⅱ study[J].Tumori,2002,88 (6):470 -473.
8[2]Sledge GW,Loehrer PJ,Roth BJ,et al.Cisplatin as firstline therapy for metastatic breast cancer.[J].J clin oncol,1988,6(12):1811-1814.
9[4]Miller AB,Hoogtraten MB,Staquet M,et al.Reporting results of cancer treatment[J].Cancer,1981,47 (1):207-214.
10[5]Wilson WH,Berg SL,Bryant G,et al.Paclitaxel in doxorubicin refractory or mitoxantrone-refractory breast cancer:a phase Ⅰ/Ⅱ trial of 96-hour infusion[J].J Clin Oncol,1994,12(8):1621-1629.
3Andersson Ⅰ.Invasive breast cancer.Eur Radiol,2001,11(suppl2):299-302.
4Gupta SK,Douglas-Jones AG,Fenn N,et al.The clinical behavior of breast carcinoma is p robably determined at the preinvasive stage(ductal carcinoma in situ).Cancer,1997,80 (9):1740-1745.
5Lassetn C,Bonadona V.Medical management of women wit hin-her-ited predisposition to breast cancer:indication sandprocedu-roce-dures for mammographic screening.Bull Cancer,2001,88 (7):677-686.
6Vibert JF,Vaileron AJ.Automatic detection of microcalcificarions in mammography using a neuromimetic system based on retina.Stud Health Technol Inform,2003,95(4):589-594.
7Paradiso A,Mangia A,Barletta A,et al.Mammography and mo-phobiologic characteristics of human breaster cancer.Tumori,1993,79(6):422426.
